Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 18 of 100
Lifestyle
Weight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By
Staff Writer
October 5, 2023
Finance
Drugs aiding weight-loss like Ozempic have so much promise, a major bank is telling investors to short junk-food credit
By
Tech Reporter
October 4, 2023
Health
Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests
By
Contributing Writer
October 2, 2023
Success
CVS is promising to boost hiring after overworked pharmacists don’t show up, but longterm solution to worker shortage is elusive
By
Josh Funk
and
The Associated Press
September 28, 2023
Commentary
Howard Dean: ‘At last, Congress proposes drug pricing reform that works’
By
Blockchain Reporter
September 19, 2023
Retail
Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By
Tech Reporter
September 5, 2023
Commentary
Smoke and mirrors: I’ve been debating Vivek Ramaswamy for 2 years. Here’s how I got past his diversionary tactics
By
Blockchain Reporter
August 31, 2023
Commentary
U.S. health care has been in crisis since Nixon–but two economists may have found a way to radically disrupt it
By
News Correspondent
August 10, 2023
Health
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By
Senior Editor
August 8, 2023
Magazine
Novo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether
By
Tech Reporter
July 31, 2023
Health
Ozempic manufacturer Novo Nordisk spent $11 million last year ‘wining and dining’ doctors. Experts slam the move as a breach of doctor-patient trust
By
Tech Reporter
July 21, 2023
Newsletters
Digitalization could be the answer to better health care for patients. But first, they need to trust it
By
Trading Desk
July 21, 2023
Health
Biden administration pushes Walgreens, CVS and Walmart to tout drug cost benefits of Inflation Reduction Act as drugmakers sue government
By
Riley Griffin
and
Bloomberg
July 19, 2023
Finance
The A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78%
By
Angel Adegbesan
and
Bloomberg
July 12, 2023
Health
Ozempic isn’t alone. A whole class of ‘revolutionary’ weight-loss drugs is on the market—but only for the wealthy
By
Contributing Writer
July 9, 2023
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Tech Reporter
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
News Correspondent
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Investment Desk